in focus
Percentage of donor organs recovered for transplant in the U.S. with machine perfusion intended or performed by donation quarter and organ
Quarters from April 1, 2015 to December 31, 2018. Based on data from the national Organ Procurement and Transplantation Network (OPTN).
Lung perfusion has more than tripled since 2015, growing from 1.7 percent to 6.3 percent and potentially expanding the pool of organs available for transplant.
The proportion of livers being treated with this transformative technology (including normothermic, hypothermic and other perfusion), also showed similar steady growth, jumping from just .1 percent in 2016 to 1.4 percent by the end of 2018. The OPTN began collecting data (from the Deceased Donor Registration) on the percentage of donor organs intended for ex vivo normothermic machine perfusion (NMP) and their location four years ago.
Read about the potential impact of NMP on transplantation and meet the companies leading the way in its development.
in focus
Number of donor organs (heart, liver, and lung) recovered for transplant in the U.S. with machine perfusion intended or performed
Based on data from the national Organ Procurement and Transplantation Network (OPTN).
In focus
Analyzing equity in access to kidney transplants in the COVID-19 era
Data show transplants for four major ethnic groups rebounded after initial decline, Hispanics had steepest decline and smallest rebound.
Analysis of allocation changes for en bloc deceased donor kidneys
Data shows that the proportion of en bloc transplants to low EPTS patients more than doubled after implementation.
Analyzing the impact of transplant policy and system modifications in response to the COVID-19 pandemic
Data reveals the community’s continued commitment to provide the best care to their patients.
Analysis of DCD heart donation on organ yield
Research shows that DCD heart donation does not impact the recovery and transplantation of other organs
